Inactive Instrument

Highlights Tekla Life Sciences Investors Nyse

Equities

End-of-day quote Nyse Other stock markets
- ^USD	-

06-10	Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2024	CI
2023	Tekla Life Sciences Investors Insider Bought Shares Worth $125,116, According to a Recent SEC Filing	MT

Abrdn Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2024	06-10	CI
Ex-dividend day	05-21	FA
Ex-dividend day	02-20	FA
Ex-dividend day	11-20	FA
Ex-dividend day	23/08/23	FA
Tekla Life Sciences Investors Declares Distribution, Payable on September 29, 2023	15/08/23	CI
Tekla Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2023	06/06/23	CI
Ex-dividend day	23/05/23	FA
Tekla Life Sciences Investors Declares Distribution, Payable on June 30, 2023	15/05/23	CI
Tekla Life Sciences Investors announces an Equity Buyback for 12% of its outstanding shares.	17/03/23	CI
Tekla Life Sciences Investors authorizes a Buyback Plan.	17/03/23	CI
Ex-dividend day	23/02/23	FA
Tekla Life Sciences Investors Declares Distribution, Payable on March 31, 2023	15/02/23	CI
Tekla Life Sciences Investors Reports Earnings Results for the Full Year Ended September 30, 2022	07/12/22	CI
Ex-dividend day	22/11/22	FA
Tekla Life Sciences Investors Declares Distribution, Payable on December 30, 2022	15/11/22	CI
Ex-dividend day	24/08/22	FA
Tekla Life Sciences Investors Declares Distribution, Payable on September 30, 2022	16/08/22	CI
Tekla Life Sciences Investors Reports Earnings Results for the Half Year Ended March 31, 2022	03/06/22	CI
Ex-dividend day	25/05/22	FA

No results for this search